Agmatine attenuates the severity of immunometabolic disorders by suppressing macrophage polarization: an in vivo study using an ulcerative colitis mouse model
PMID: 39413617
Source: Biomed Pharmacother
Publication date:
2025-07-24
Year:
2024
Abstract
NULL